STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 74 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $62,000 | +51.2% | 5,841 | +48.6% | 0.00% | – |
Q3 2019 | $41,000 | -21.2% | 3,932 | +16.6% | 0.00% | – |
Q2 2019 | $52,000 | +1200.0% | 3,371 | +730.3% | 0.00% | – |
Q4 2018 | $4,000 | +33.3% | 406 | +107.1% | 0.00% | – |
Q3 2018 | $3,000 | 0.0% | 196 | 0.0% | 0.00% | – |
Q2 2018 | $3,000 | -96.7% | 196 | -97.1% | 0.00% | – |
Q4 2016 | $90,000 | +50.0% | 6,836 | +24.8% | 0.00% | – |
Q3 2016 | $60,000 | +1400.0% | 5,478 | +2182.5% | 0.00% | – |
Q2 2014 | $4,000 | – | 240 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eventide Asset Management | 579,800 | $7,224,000 | 1.01% |
VHCP Management, LLC | 71,000 | $884,000 | 0.40% |
Healthcare Value Capital, LLC | 16,464 | $205,000 | 0.20% |
CARL DOMINO INC | 22,196 | $277,000 | 0.15% |
TFS CAPITAL LLC | 120,112 | $1,497,000 | 0.13% |
Private Capital Advisors, Inc. | 31,064 | $387,000 | 0.12% |
Artal Group S.A. | 170,000 | $2,118,000 | 0.08% |
TimesSquare Capital Management, LLC | 801,225 | $9,983,000 | 0.06% |
Baker Brothers Advisors | 338,671 | $4,220,000 | 0.05% |
STONERIDGE INVESTMENT PARTNERS LLC | 19,399 | $242,000 | 0.04% |